The Study Builder Revolution: Advancing Patient-Centric Clinical Trials

This blog was authored by Matt Noble, SVP, Product Management, Patient Cloud at Medidata.

DCTs! Sensors! ePROs! All represent crucial elements to cultivating more patient-centric experiences in clinical trials. To get there, we rely on the extensive knowledge and expertise of investigators, clinical operations and regulatory professionals, patients, advocates, and everyone else in-between. There’s one key persona in the mix, however, that we should cast into the spotlight—the unsung hero laying the foundation of the multifaceted Medidata Patient Cloud user experience: the study builder!

For decades, Medidata Rave EDC—and subsequently our beyond-Rave platform, including Patient Cloud— excelled in the market because of how configurable it is. You can do anything in Rave Architect, especially when coupled with a custom function. The most complicated, multi-arm, double-blinded study? No problem at all! Behind each of those complicated Rave builds was an implementation consultant here at Medidata, or at one of our CRO partners or sponsors, racking their brains for creative ways to make it all happen.

Enter Designer, Medidata’s powerful study implementation tool. This streamlined and intuitive UX helps to optimize workflow efficiency and minimize errors—a game changer for study builders navigating complex clinical trials. With straightforward navigation, intuitive interfaces, and contextual guidance, Designer empowers study builders to configure trials with precision and confidence, reducing the risk of oversights or misconfigurations that could compromise data integrity.

But the impact of an exceptional UX goes beyond the individual study builder. It enables collaboration, innovation, and speed among multidisciplinary trial design and management teams.

By democratizing access to powerful configuration tools and fostering a user-friendly environment, Medidata's platform becomes a catalyst for discovery.

A wide range of stakeholders can leverage the dynamic platform to concurrently share their specialized knowledge and insights, enabling more efficient support of study builds and ongoing maintenance. Such environments drive iterative improvements over the trial lifecycle.

What's the Takeaway?

There’s a shared mission to prioritize enhancements to, and the development of, products that solve the pain points of our core users. Let's keep making impactful advancements on all of them. We must empower trial study builders with intuitive tools and interfaces. By doing so, Medidata will continue transforming complex trial designs into actionable insights, ultimately improving patient outcomes and shaping the future of healthcare.

Learn how Medidata can further support your study builds here.